Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;62(1):225-56.
doi: 10.1016/j.pcl.2014.09.015.

Neuroblastoma: paradigm for precision medicine

Meredith S Irwin  1 , Julie R Park  2
Affiliations
Review

Neuroblastoma: paradigm for precision medicine

Meredith S Irwin et al. Pediatr Clin North Am. 2015 Feb.

Abstract

Neuroblastoma (NB) is the third most common pediatric cancer. Although NB accounts for 7% of pediatric malignancies, it is responsible for more than 10% of childhood cancer-related mortality. Prognosis and treatment are determined by clinical and biological risk factors. Estimated 5-year survival rates for patients with non-high-risk and high-risk NB are more than 90% and less than 50%, respectively. Recent clinical trials have continued to reduce therapy for patients with non-high-risk NB, including the most favorable subsets who are often followed with observation approaches. In contrast, high-risk patients are treated aggressively with chemotherapy, radiation, surgery, and myeloablative and immunotherapies.

Keywords: ALK (anaplastic lymphoma kinase); Immunotherapy; MYCN; Myeloablative therapy (MAT); Neuroblastoma; Phox2B; Risk stratification; Segmental chromosome aberrations (SCA).

PubMed Disclaimer